• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis.

作者信息

Sposato B, Scalese M, Camiciottoli G, Carpagnano G E, Pelaia C, Santus P, Maniscalco M, Corsico A, Grosso A, Baglioni S, Murgia N, Folletti I, Pelaia G, Masieri S, Cavaliere C, Musarra A, Bargagli E, Ricci A, Latorre M, Rogliani P, Paggiaro P

机构信息

Azienda USL Toscana Sud-Est Pneumology Department, "Misericordia" Hospital, Grosseto, Italy; Experimental Medicine and Systems, "PhD program" Department of Systems Medicine University of Rome "Tor Vergata", Rome, Italy.

Clinic Physiology Institute, National Research Centre, Pisa, Italy.

出版信息

Respir Med Res. 2020 Nov;78:100791. doi: 10.1016/j.resmer.2020.100791. Epub 2020 Sep 21.

DOI:10.1016/j.resmer.2020.100791
PMID:33039948
Abstract
摘要

相似文献

1
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis.美泊利单抗在重度嗜酸性粒细胞性哮喘伴鼻息肉患者中的实际疗效。
Respir Med Res. 2020 Nov;78:100791. doi: 10.1016/j.resmer.2020.100791. Epub 2020 Sep 21.
2
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.美泊利珠单抗改善伴有鼻息肉的慢性鼻-鼻窦炎和重度嗜酸性粒细胞性哮喘患者的鼻窦-鼻部症状和哮喘控制：一项为期 12 个月的真实世界研究。
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211009398. doi: 10.1177/17534666211009398.
3
Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.美泊利珠单抗治疗伴有/不伴有鼻息肉的重度嗜酸性粒细胞性哮喘患者的有效性：一项真实世界研究。
Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30.
4
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy.伴有鼻息肉的重度嗜酸性粒细胞性哮喘：一种使用美泊利单抗治疗可改善鼻窦和哮喘预后的表型。
J Allergy Clin Immunol. 2020 Jun;145(6):1713-1715. doi: 10.1016/j.jaci.2020.02.002. Epub 2020 Feb 19.
5
Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps.贝那利珠单抗、美泊利珠单抗和奥马珠单抗在与鼻息肉相关的重度过敏性哮喘中的实际疗效。
Clin Rev Allergy Immunol. 2023 Apr;64(2):179-192. doi: 10.1007/s12016-022-08938-w. Epub 2022 Apr 14.
6
Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.按年龄和哮喘发病年龄划分的可接受美泊利珠单抗治疗的重度哮喘患者比例。
J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2689-2696.e2. doi: 10.1016/j.jaip.2019.05.053. Epub 2019 Jun 13.
7
Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.严重哮喘患者的上下气道炎症：精准生物治疗的指导。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620965151. doi: 10.1177/1753466620965151.
8
Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps.美泊利单抗对重度嗜酸性粒细胞性哮喘和伴鼻息肉的慢性鼻-鼻窦炎的疗效存在脱节。
J Allergy Clin Immunol Pract. 2020 May;8(5):1714-1716. doi: 10.1016/j.jaip.2020.01.009. Epub 2020 Jan 15.
9
REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps.REDES研究：美泊利单抗对重度哮喘合并鼻息肉患者有效。
J Investig Allergol Clin Immunol. 2023 Dec 14;33(6):476-479. doi: 10.18176/jiaci.0905. Epub 2023 Jun 9.
10
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.美泊利珠单抗可减少重度鼻息肉患者的手术需求：一项随机试验。
J Allergy Clin Immunol. 2017 Oct;140(4):1024-1031.e14. doi: 10.1016/j.jaci.2017.05.044. Epub 2017 Jul 4.

引用本文的文献

1
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study.美泊利珠单抗改善重度哮喘患者慢性鼻-鼻窦炎伴鼻息肉的预后：一项多中心真实世界研究
J Pers Med. 2022 Aug 10;12(8):1304. doi: 10.3390/jpm12081304.